A comparative study of quantitative structure activity relationship methods based on antitumor diarylsulfonylureas

被引:16
作者
Choo, HYP [1 ]
Lim, JS
Kam, Y
Kim, SY
Lee, J
机构
[1] Ewha Womans Univ, Sch Pharm, Seoul 120750, South Korea
[2] Seoul Natl Univ, Sch Pharm, Seoul, South Korea
基金
新加坡国家研究基金会;
关键词
antitumor activity; diarylsulfonylureas; biological activities;
D O I
10.1016/S0223-5234(01)01276-4
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
A series of 28 diarylsulfonylureas with antitumor activity was subjected to a three-dimensional quantitative activity relationship (3D-QSAR) study. Three different QSAR methods, comparative molecular field analysis (CoMFA), hologram QSAR (HQSAR) and comparative molecular similarity indices analysis (CoMSIA), were compared in terms of their potential for predictability. All three QSAR-based models had good predictability and yielded q(2) values 0.74, 0.63 and 0.72, respectively. The CoMFA model provided the highest q(2) and r(2) values, which implied the significance of correlation of steric and electrostatic fields with biological activities. The number of components was 3-4 for all three QSAR methods. The quality of HQSAR or CoMSIA was slightly lower than that of CoNFA in terms of q(2) and r(2) values. HQSAR does not require the generation of a three-dimensional structure of molecules and CoMSIA does not require molecular superposition, therefore they are faster than CoMFA in data processing. (C) 2001 Editions scientifiques et medicales Elsevier SAS.
引用
收藏
页码:829 / 836
页数:8
相关论文
共 20 条
[1]  
[Anonymous], 3D QSAR DRUG DESIGN
[2]   CROSS-VALIDATED R(2)-GUIDED REGION SELECTION FOR COMPARATIVE MOLECULAR-FIELD ANALYSIS - A SIMPLE METHOD TO ACHIEVE CONSISTENT RESULTS [J].
CHO, SJ ;
TROPSHA, A .
JOURNAL OF MEDICINAL CHEMISTRY, 1995, 38 (07) :1060-1066
[3]   COMPARATIVE MOLECULAR-FIELD ANALYSIS (COMFA) .1. EFFECT OF SHAPE ON BINDING OF STEROIDS TO CARRIER PROTEINS [J].
CRAMER, RD ;
PATTERSON, DE ;
BUNCE, JD .
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY, 1988, 110 (18) :5959-5967
[4]  
DEAN PM, 1993, 3D QSAR DRUG DESIGN, P150
[5]  
EHJARDT WJ, 1991, J DRUG METAB DISPOS, V19, P370
[6]   Antitumor diarylsulfonylureas: Novel agents with unfulfilled promise [J].
Houghton, PJ ;
Houghton, JA .
INVESTIGATIONAL NEW DRUGS, 1996, 14 (03) :271-280
[7]  
HOWBERT J J, 1991, Drugs of the Future, V16, P517
[8]   NOVEL AGENTS EFFECTIVE AGAINST SOLID TUMORS - THE DIARYLSULFONYLUREAS - SYNTHESIS, ACTIVITIES, AND ANALYSIS OF QUANTITATIVE STRUCTURE-ACTIVITY-RELATIONSHIPS [J].
HOWBERT, JJ ;
GROSSMAN, CS ;
CROWELL, TA ;
RIEDER, BJ ;
HARPER, RW ;
KRAMER, KE ;
TAO, EV ;
AIKINS, J ;
POORE, GA ;
RINZEL, SM ;
GRINDEY, GB ;
SHAW, WN ;
TODD, GC .
JOURNAL OF MEDICINAL CHEMISTRY, 1990, 33 (09) :2393-2407
[9]   Planar structural requirement at 4-position of 1-arylsulfonyl-4-phenyl-4,5-dihydro-2-imidazolones for their cytotoxicity [J].
Jung, SH ;
Kwak, SJ .
ARCHIVES OF PHARMACAL RESEARCH, 1997, 20 (03) :283-287
[10]   Synthesis and evaluation of cytotoxicity of novel arylsulfonylimidazolidinones containing sulfonylurea pharmacophore [J].
Jung, SH ;
Song, JS ;
Lee, HS ;
Choi, SU ;
Lee, CO .
ARCHIVES OF PHARMACAL RESEARCH, 1996, 19 (06) :570-580